Cited by 192Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model OrganismsMesenchymal stem cell research

The DOI matches its Crossref record; 179 of the 181 references it cites were found in a registry or an index.

Senescent cells: a therapeutic target for cardiovascular disease

Open access
Childs, Bennett G., Li, Hu, van Deursen, Jan M.·2018·Journal of Clinical Investigation

Abstract

Cellular senescence, a major tumor-suppressive cell fate, has emerged from humble beginnings as an in vitro phenomenon into recognition as a fundamental mechanism of aging. In the process, senescent cells have attracted attention as a therapeutic target for age-related diseases, including cardiovascular disease (CVD), the leading cause of morbidity and mortality in the elderly. Given the aging global population and the inadequacy of current medical management, attenuating the health care burden of CVD would be transformative to clinical practice. Here, we review the evidence that cellular senescence drives CVD in a bimodal fashion by both priming the aged cardiovascular system for disease and driving established disease forward. Hence, the growing field of senotherapy (neutralizing senescent cells for therapeutic benefit) is poised to contribute to both prevention and treatment of CVD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci95146

Cites

179 of 179 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Flagged first, then by citations

Show all 181 references

2 of the 181 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. John M. Eisenberg Center for Clinical Decisions and Communications Science. Treatments for open-angle glaucoma: a review of the research for adults. In: Comparative Effectiveness Review Summary Guides for Consumers [Internet]. Rockville, Maryland, USA: Agency for Healthcare Research and Quality; 2005. https://www.ncbi.nlm.nih.gov/books/NBK131775/ Accessed January 29, 2018
  2. 10.1016/j.cell.2008.06.049 · DOI · Paper page

Cited by

Sorted by citations

Items 101–192 of 192

Metadata

Authors
Childs, B. G., Li, H., & van Deursen, J. M.
Affiliations
Mayo Clinic (US)
Venue
Journal of Clinical Investigation
Published
2018-04-02
Volume
128
Issue
4
Pages
1217-1228
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2795134170
Cited by
192
References
181
Citations by year
2026: 17 · 2025: 21 · 2024: 13 · 2023: 24 · 2022: 32 · 2021: 35 · 2020: 27 · 2019: 16 · 2018: 7
FWCI
2.80
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion, other-oa)
Funders
  • Glenn Foundation for Medical Research
  • Fondation pour la Recherche Médicale
  • National Institutes of Health
  • National Institute on Aging (R01AG057493, T32AG049672)
  • National Cancer Institute (R01CA126828, R01CA096985)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Keywords
cellular senescence, senolytics, senotherapy, cardiovascular disease, aging, age-related diseases, senolytic therapy, cardiovascular aging
MeSH terms
Aged, Aging, Animals, Cardiovascular Diseases, Cardiovascular System, Humans, Cellular Senescence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review